Hana Pharm Co Ltd
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and an… Read more
Hana Pharm Co Ltd (293480) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.005x
Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of -0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.41 Billion) by net assets (₩306.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hana Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LivePerson Inc
NASDAQ:LPSN
|
4.335x |
|
SFOODS
HE:SFOODS
|
0.018x |
|
Pan Brothers Tbk
JK:PBRX
|
0.059x |
|
LGL Group Inc
NYSE MKT:LGL
|
0.007x |
|
Argo Group International Holdings Ltd
OTCQX:ARGHF
|
-1.403x |
|
Arrienda Rental Properties SOCIMI SA
MC:YARP
|
0.052x |
|
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
|
0.012x |
|
Trident Digital Tech Holdings Ltd American Depository Shares
NASDAQ:TDTH
|
0.658x |
Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩309.18 Billion | ₩25.30 Billion | 0.082x | +23.60% |
| 2023-12-31 | ₩277.98 Billion | ₩18.40 Billion | 0.066x | -42.46% |
| 2022-12-31 | ₩268.40 Billion | ₩30.88 Billion | 0.115x | +12.98% |
| 2021-12-31 | ₩251.90 Billion | ₩25.66 Billion | 0.102x | +51.91% |
| 2020-12-31 | ₩232.38 Billion | ₩15.58 Billion | 0.067x | -53.43% |
| 2019-12-31 | ₩220.33 Billion | ₩31.72 Billion | 0.144x | +7.17% |
| 2018-12-31 | ₩205.39 Billion | ₩27.59 Billion | 0.134x | -56.98% |
| 2017-12-31 | ₩81.30 Billion | ₩25.38 Billion | 0.312x | +38.97% |
| 2016-12-31 | ₩55.48 Billion | ₩12.46 Billion | 0.225x | -- |